Health
Baricitinib treatment linked to reduced mortality in COVID-19 patients – Medical Xpress
The rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to severe COVID-19, according to translational research…
The rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to severe COVID-19, according to translational research by an international team coordinated by researchers from Karolinska Institutet in Sweden. The findings, published in the journal Science Advances, support the continuation of ongoing randomized clinical trials.
“We are pleased to report a 71 percent reduction in mortality for the group receiving baricitinib in addition to standard…
-
Business23 hours agoCan Netflix Stock Continue to Soar in 2025?
-
Noosa News23 hours agoWinter cold snap heralds beginning of south-east Queensland dry season
-
Noosa News7 hours agoLast Eungella dairy farm closing as milk becomes ‘cheaper than water’
-
Noosa News7 hours agoMan, 21, rushed to hospital after shooting outside home in Parkwood on the Gold Coast